Nanoformulation of a Novel Pyrano[2,3-c] Pyrazole Heterocyclic Compound AMDPC Exhibits Anti-Cancer Activity via Blocking the Cell Cycle through a P53-Independent Pathway

Pyrano[2,3-c]pyrazole derivatives have been reported as exerting various biological activities. One compound with potential anti-tumor activity was screened out by MTT assay from series of dihydropyrazopyrazole derivatives we had synthesized before using a one-pot, four-component reaction, and was n...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xuanrong, Zhang, Longchao, Gao, Mengshi, Que, Xiangjie, Zhou, Chenfeng, Zhu, Dabu, Cai, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6384735/
https://www.ncbi.nlm.nih.gov/pubmed/30754632
http://dx.doi.org/10.3390/molecules24030624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6384735/
https://www.ncbi.nlm.nih.gov/pubmed/30754632
http://dx.doi.org/10.3390/molecules24030624

Ejemplares similares